Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
GURU Organic Energy Announces Appointment of New Executive Vice President, Sales
-
Revive Therapeutics Provides Update on Research Study Evaluating Bucillamine for Nerve Agent Exposure
-
23andMe Launches Discover23 to Help Accelerate Large-Scale Genetics Research For Biopharma Collaborators, Powered By Lifebit’s Trusted Technology
-
Atsena Therapeutics Initiates Part B of Phase I/II Clinical Trial Evaluating Gene Therapy ATSN-201 to Treat X-linked Retinoschisis
-
RAID: Shadow Legends Steps Into the Rabbit Hole with ‘RAID: Alice’s Adventure’ Special Event
-
PortIO Completes Keiretsu Forum MST Due Diligence, Paving the Way for Fast-Track Funding
-
Arch Biopartners Announces Ontario Research Ethics Board Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery-Associated Acute Kidney Injury (CS-AKI)
-
Lithium Argentina Provides 2024 Production Results, 2025 Guidance and Update on Special Meeting of Shareholders
-
Form 8.3 - Learning Technologies Group plc - Octopus Investments
-
uniQure Announces Pricing of its Public Offering
-
Centessa Pharmaceuticals Announces Appointment of Stephen Kanes, MD PhD, as Chief Medical Officer
-
RCLCO Ranks Summerlin® and Bridgeland® Among Nation’s Top 10 Best-Selling Master Planned Communities of 2024
-
CommunityAmerica Credit Union Accelerates St. Louis Expansion, Merging with Electro Savings Credit Union
-
CURRENC Debuts SEAMLESS AI Call Centre Solutions
-
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
-
BexBack Offers 100x Leverage, Double Deposit Bonus and $50 Welcome Bonus for New Users—No KYC Required
-
Lithium Ionic: 2024 Year-in-Review, Setting Stage for a Pivotal 2025
-
Microbix Expanding Addressable Market Share with Test Makers Augmenting its Recombinant Antigen Capabilities for Immunoassay Markets
-
Lantronix CEO Saleel Awsare Named “IoT Company CEO of the Year” in 2025 IoT Breakthrough Awards Program
-
Volvo Cars Canada named official automotive partner of Canada Snowboard
-
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
-
AI-Driven Crypto research platform SoSoValue raises $15 million Series A to launch the Investible Spot Index Protocol SSI
-
ASDSA Finds Lack of Physician Supervision in Medical Spas
-
Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer
-
Ocular Therapeutix™ to Provide Corporate Update During 43rd Annual J.P. Morgan Healthcare Conference Presentation
-
LB Pharmaceuticals Announces Positive Topline Results from Phase 2 Trial of LB-102 in Schizophrenia
-
The Simply Good Foods Company Reports Fiscal First Quarter 2025 Financial Results and Reaffirms Fiscal Year 2025 Outlook
-
FDA Accepts Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and Transfusion-Dependent Alpha- or Beta-Thalassemia
-
Kamada Affirms 2024 Financial Guidance and Announces Expected Continued Double-Digit Profitable Growth for 2025
-
Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
-
BioStem Technologies Launches Clinical Trial to Demonstrate the Therapeutic Benefits of its BioREtain® Technology in Treating Diabetic Foot Ulcers Using Vendaje®
-
Tonix Pharmaceuticals Further Strengthens Commercial Leadership Team with Appointment of Gary Ainsworth as Vice President of Market Access
-
Standard BioTools SomaScan Assay Powers Key Insights into Semaglutide Treatment Published in Nature Medicine
-
Opthea to Host Investor Days in New York and Australia
-
Atea Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
-
Tiziana Life Sciences Announces Review Article Published in Nature Highlighting Foralumab's Potential in the Treatment of Neurological Disease
-
BitFuFu Unveils BitFuFuOS Software Service to Boost Mining Revenue by up to 20%
-
Bitfarms to Present at Needham Growth Conference in NYC
-
Absci and AMD Announce Collaboration and Strategic Investment to Accelerate the Future of AI Drug Discovery
-
CEPI and Micron Biomedical Accelerate Needle-Free Vaccines against Disease X with $3.7 Million Grant to Advance Learnings from COVID-19
-
Talisker Announces Mining Contractor Mobilization and Initiation of Pre-operation Activities at the Bralorne Gold Project
-
Verve Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
SweetWater Brewing Launches Daytrip IPA: A New Tropical Escape in Every Sip
-
AI-Driven Crypto research platform SoSoValue raises $15 million Series A to launch the Investible Spot Index Protocol SSI
-
Solaris Expands Leadership Team
-
Alpha Liquid Terminal Debuts First Dedicated Web3 Node on ChromeOS to Power AI Trading
-
iTeos to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
C4 Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
-
EsoBiotec Doses First Patient in Investigator Initiated Trial of In Vivo BCMA CAR-T Candidate ESO-T01 for Multiple Myeloma
